Literature DB >> 16542195

Monitoring for harms of therapy.

J K Aronson.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16542195      PMCID: PMC1885033          DOI: 10.1111/j.1365-2125.2006.02648.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  2001       Impact factor: 4.335

Review 2.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2001       Impact factor: 4.335

Review 3.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

4.  Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. 1983.

Authors:  L Lennard; C A Rees; J S Lilleyman; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

5.  Monitoring therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

Review 6.  Monitoring for adverse drug reactions.

Authors:  J J Coleman; R E Ferner; S J W Evans
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

Review 7.  The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.

Authors:  S A Coulthard; E C Matheson; A G Hall; L A Hogarth
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2004-10       Impact factor: 1.381

Review 8.  Analytic aspects of monitoring therapy with thiopurine medications.

Authors:  Victor W Armstrong; Maria Shipkova; Nicolas von Ahsen; Michael Oellerich
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

  8 in total
  1 in total

Review 1.  A strategy for regulatory action when new adverse effects of a licensed product emerge.

Authors:  Jeffrey K Aronson; Deirdre Price; Robin E Ferner
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.